Skip Navigation

Journal of Tropical Pediatrics 2002 48(6):366-370; doi:10.1093/tropej/48.6.366
© 2002 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jaja, S. I.
Right arrow Articles by Temiye, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaja, S. I.
Right arrow Articles by Temiye, E. O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Blood Pressure, Hematologic and Erythrocyte Fragility Changes in Children Suffering from Sickle Cell Anemia following Ascorbic Acid Supplementation

S. I. Jaja1, A. R. Ikotun1, S. Gbenebitse1 and E. O. Temiye2

1 Department of Physiology, College of Medicine, University of Lagos, Nigeria 2 Department of Pediatrics, College of Medicine, University of Lagos, Nigeria

The effect of ascorbic acid supplementation (100 mg/day for 6 weeks) on blood pressure, packed cell volume, irreversibly sickled cells, per cent fetal hemoglobin, hemoglobin concentration, and erythrocyte osmotic fragility was assessed in children suffering from sickle cell anemia. Fifteen children whose ages ranged from 4 to 11 years (7.5 ± 0.75 years) were studied. Ascorbic acid supplementation reduced systolic blood pressure by 10.9 ± 3.4 mmHg (p < 0.01), diastolic blood pressure by 7.3 ± 2.0 mmHg (p < 0.01) and mean arterial pressure by 9.4 ± 2.6 mmHg (p < 0.01). It significantly increased packed cell volume (p < 0.001), hemoglobin concentration (p < 0.001) and per cent fetal hemoglobin (p < 0.001), but reduced per cent irreversibly sickled cells (p < 0.001). Ascorbic acid supplementation also abolished the long tail of the erythrocyte osmotic fragiligram and increased the resistance of the cells to lysis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.